Literature DB >> 35982154

Ptchd1 mediates opioid tolerance via cholesterol-dependent effects on μ-opioid receptor trafficking.

Nycole Maza1, Dandan Wang2, Cody Kowalski1, Hannah M Stoveken1, Maria Dao1, Omar K Sial1, Andrew C Giles1, Brock Grill3,4,5, Kirill A Martemyanov6.   

Abstract

Repeated exposure to opioids causes tolerance, which limits their analgesic utility and contributes to overdose and abuse liability. However, the molecular mechanisms underpinning tolerance are not well understood. Here, we used a forward genetic screen in Caenorhabditis elegans for unbiased identification of genes regulating opioid tolerance which revealed a role for PTR-25/Ptchd1. We found that PTR-25/Ptchd1 controls μ-opioid receptor trafficking and that these effects were mediated by the ability of PTR-25/Ptchd1 to control membrane cholesterol content. Electrophysiological studies showed that loss of Ptchd1 in mice reduced opioid-induced desensitization of neurons in several brain regions and the peripheral nervous system. Mice and C. elegans lacking Ptchd1/PTR-25 display similarly augmented responses to opioids. Ptchd1 knockout mice fail to develop analgesic tolerance and have greatly diminished somatic withdrawal. Thus, we propose that Ptchd1 plays an evolutionarily conserved role in protecting the μ-opioid receptor against overstimulation.
© 2022. The Author(s), under exclusive licence to Springer Nature America, Inc.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35982154     DOI: 10.1038/s41593-022-01135-0

Source DB:  PubMed          Journal:  Nat Neurosci        ISSN: 1097-6256            Impact factor:   28.771


  57 in total

Review 1.  Desensitization of G protein-coupled receptors and neuronal functions.

Authors:  Raul R Gainetdinov; Richard T Premont; Laura M Bohn; Robert J Lefkowitz; Marc G Caron
Journal:  Annu Rev Neurosci       Date:  2004       Impact factor: 12.449

Review 2.  Opioid tolerance: the clinical perspective.

Authors:  B J Collett
Journal:  Br J Anaesth       Date:  1998-07       Impact factor: 9.166

3.  Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene.

Authors:  H W Matthes; R Maldonado; F Simonin; O Valverde; S Slowe; I Kitchen; K Befort; A Dierich; M Le Meur; P Dollé; E Tzavara; J Hanoune; B P Roques; B L Kieffer
Journal:  Nature       Date:  1996-10-31       Impact factor: 49.962

Review 4.  Opioid Tolerance in Critical Illness.

Authors:  J A Jeevendra Martyn; Jianren Mao; Edward A Bittner
Journal:  N Engl J Med       Date:  2019-01-24       Impact factor: 91.245

Review 5.  Structure and dynamics of GPCR signaling complexes.

Authors:  Daniel Hilger; Matthieu Masureel; Brian K Kobilka
Journal:  Nat Struct Mol Biol       Date:  2018-01-08       Impact factor: 15.369

Review 6.  Perioperative opioid analgesia-when is enough too much? A review of opioid-induced tolerance and hyperalgesia.

Authors:  Lesley A Colvin; Fiona Bull; Tim G Hales
Journal:  Lancet       Date:  2019-04-13       Impact factor: 79.321

Review 7.  RGS proteins have a signalling complex: interactions between RGS proteins and GPCRs, effectors, and auxiliary proteins.

Authors:  Maria Abramow-Newerly; Anju A Roy; Caroline Nunn; Peter Chidiac
Journal:  Cell Signal       Date:  2005-10-13       Impact factor: 4.315

Review 8.  Regulation of μ-opioid receptors: desensitization, phosphorylation, internalization, and tolerance.

Authors:  John T Williams; Susan L Ingram; Graeme Henderson; Charles Chavkin; Mark von Zastrow; Stefan Schulz; Thomas Koch; Christopher J Evans; Macdonald J Christie
Journal:  Pharmacol Rev       Date:  2013-01-15       Impact factor: 25.468

Review 9.  Opioid receptors: drivers to addiction?

Authors:  Emmanuel Darcq; Brigitte Lina Kieffer
Journal:  Nat Rev Neurosci       Date:  2018-08       Impact factor: 34.870

10.  Loss of μ opioid receptor signaling in nociceptors, but not microglia, abrogates morphine tolerance without disrupting analgesia.

Authors:  Gregory Corder; Vivianne L Tawfik; Dong Wang; Elizabeth I Sypek; Sarah A Low; Jasmine R Dickinson; Chaudy Sotoudeh; J David Clark; Ben A Barres; Christopher J Bohlen; Grégory Scherrer
Journal:  Nat Med       Date:  2017-01-16       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.